LAMP2 and plasma cell myeloma: We observed significantly higher surface CD107a and CD107b expression in BM MNCs from patients treated with 1 nmol/L SAR442257, demonstrating that multiple myeloma cell killing occurs in concert with T-cell degranulation (Fig. 2B).